Prateet Minhas as Head of Market Access for Europe and Emerging Markets

LONDON – SEPTEMBER 2022 – Today, Patrick Romano and Marcus Deans, Partners and Co-founders of Eradigm Consulting, announce the hiring of Dr. Prateet Minhas, MBBS, MBA to head up Eradigm Consulting’s Market Access Advisory division. This hire represents a further commitment to our world-class client base to continue to broaden the breadth and depth of our suite of advisory services.

As a trained physician and globally recognised leader in life science consulting, Dr. Minhas brings over 15 years of experience in supporting biopharmaceutical clients to secure market access to therapies at the optimal price across Europe and Emerging Markets. Dr. Minhas will bring his expertise to deliver projects to Eradigm’s client base in areas relating to Pricing, Payer value proposition, Evidence generation planning, Launch planning as well as HTA negotiations with country payers.

Prior to joining Eradigm Consulting, Dr. Minhas was a Director at Syneos Health for more than a decade, helping companies develop strategic and tactical market access plans where he successfully lead and delivered over 250 consulting engagements.

Dr. Minhas has supported various clients in HTA negotiations with payers in Brazil, China, Denmark, Finland, Italy, Norway, Spain, and Sweden. His hands-on experience of negotiating with payers and authorities has enabled him to provide actionable recommendations to clients and support them in the complete journey from strategy development to actual reimbursement and access for therapies. Dr. Minhas earned an MBA with merit from Imperial College London. He is also a trained physician with an MBBS from Maulana Azad Medical College in New Delhi, India.

Dr. Minhas says: ”I couldn’t be more pleased to be joining Patrick, Marcus and their extraordinary team. They have built an incredible culture of excellence in all they do, and I am thrilled to be able to build on the Market Access expertise they have already established within their impressive client base.”

“With demand for our services in Market Access growing at pace, it’s fantastic to bring in Prateet’s combination of technical pricing expertise and extensive pharma industry knowledge. There’s no doubt that this partnership will deliver huge benefits for our biotech and pharma clients who are looking to double down on ensuring optimal market access in ex-US markets. It’s brilliant to continue to build out the experience and wisdom within our senior team.” says Patrick Romano, Senior Partner at Eradigm Consulting.

With additional expertise in the hiring pipeline, this is the first in a series of discrete investments that Eradigm will be making to bolster the Market Access division in the coming months.

Dr. Minhas will be leading Eradigm’s delegation at #ISPOR 2022 and looks forward to meeting clients old and new in Vienna, Austria, November 4th-7th.